Euromed at Vitafoods Asia: Reading the Botanical Claims

In coverage published on September 24, 2026, NutritionInsight reported on Euromed’s botanical ingredient presentation at Vitafoods Asia 2026. The discussion connected pomegranate and persimmon extracts with beauty-from-within, healthy aging and weight management.

For readers interested in skin and long-term wellbeing, the story offers a useful opportunity to separate ingredient positioning from clinical evidence. The key question is not simply which plants were discussed. It is what the supporting research actually measured.

Why Euromed linked botanicals with beauty and healthy aging

According to NutritionInsight, Euromed scientific marketing specialist Silvia Mont Darley discussed two branded extracts. Each was presented with a different set of proposed benefits.

Pomanox: Pomegranate extract and skin health

NutritionInsight reports that Euromed discussed Pomanox as a pomegranate extract positioned for skin health and healthy aging. That identifies the ingredient and its intended area of use.

perFix: Persimmon extract and metabolic-health positioning

NutritionInsight reports that Euromed described perFix as having potential to support fat loss, lean mass and mood. The qualified wording belongs to the company’s presentation. It should be read as a statement of proposed benefit rather than a result established by the event report.

The presentation also fits a wider event conversation. NutritionInsight’s broader Vitafoods Asia recap describes healthy longevity as a prominent theme. It reports discussion of metabolic health and microbiome-related topics, alongside muscle preservation and new delivery formats.

That context helps explain why beauty and metabolic-health language appeared together in Euromed’s presentation.

Why the study details matter more than the event theme

The available NutritionInsight report names the ingredients and areas of interest but does not provide the clinical details needed to judge efficacy. Specifically, it does not supply:

• Study designs or participant numbers.
• Formulations and doses used in the research.
• Study durations or comparison groups.
• Numerical outcomes or statistical results.

Without those details, the size and reliability of any effect cannot be assessed from this coverage. Its relevance to a particular reader is also unresolved. This is a limitation of the available report, not proof that the extracts are ineffective.

Source roles matter too. Mont Darley is identified as Euromed’s scientific marketing specialist. The accessible report contains no direct quotations from study authors or independent experts, so the discussion should not be read as independent clinical assessment.

NutritionInsight also says the interview touched on holistic metabolic health and weight management in the GLP-1 era. It does not describe a specific approach, medication regimen or interaction evidence. That reference is not a recommendation to combine either extract with prescription medication.

How to assess the claims before considering a supplement

The practical value of this news is a better way to read a supplement claim. Before drawing conclusions about either extract, look for the actual study report and work through the following questions.

1. Does the research match the product? Check the formulation and dose described in the study against the branded extract being discussed. The useful question is whether the evidence belongs to the specific preparation under consideration, rather than simply to pomegranate or persimmon as a general category.
2. Who participated and for how long? Read the participant description and study duration before deciding whether the results are relevant to your question. These are part of assessing applicability. A broad healthy-aging claim should lead back to a clearly described group and a defined observation period.
3. Which outcome was actually measured? For Pomanox, ask what the researchers meant by skin health. For perFix, ask whether fat loss, lean mass and mood were assessed separately. Keep each claim tied to its own reported outcome rather than treating a general wellness description as evidence for every proposed benefit.
4. What was the comparison and the result? Look for the comparator and the numerical findings together. Then ask whether the reported difference was statistically supported and whether its size would matter in practice. This is the point at which a proposed benefit can be evaluated as a research result.

A useful study summary should let you complete a straightforward sentence: this preparation was tested in this group against this comparator for this outcome. That exercise keeps a broad beauty-from-within story connected to a concrete research question. It also separates interest in a botanical ingredient from a decision about a finished supplement.

These questions are an evidence-reading framework, not a reason to add either product to a daily routine. Personal decisions about supplements or their use alongside medication belong with a qualified healthcare professional.

For related context, Younell’s guide to separating supplement interest from evidence addresses another way that attention and outcomes can become confused. Our discussion of reading plant-compound claims carefully offers a broader editorial lens on ingredient stories.

Why the next useful update is the underlying research

Euromed’s Vitafoods Asia presentation shows how pomegranate and persimmon extracts are being positioned across beauty and healthy-aging conversations. The useful next step is to examine identifiable research on the specific preparations and the outcomes attached to them.

For readers, the most constructive response is informed curiosity rather than an immediate purchase. The question for future reporting is specific: do these particular extracts produce meaningful changes in the outcomes used to promote them, and for whom?

Sources

1. Vitafoods Asia 2026: Euromed’s Mediterranean botanicals
2. 2027 nutrition trends, omega-3 supply & Nestlé VMS sale